Cargando…

Engaging the Canadian public on reimbursement decision-making for drugs for rare diseases: a national online survey

BACKGROUND: Funding of drugs for rare diseases (DRDs) requires decisions that balance fairness for all individuals within the healthcare system with compassion for affected individuals. Our study objective was to conduct a national online survey to determine the Canadian public’s perspective, includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polisena, Julie, Burgess, Michael, Mitton, Craig, Lynd, Larry D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446683/ https://www.ncbi.nlm.nih.gov/pubmed/28549479 http://dx.doi.org/10.1186/s12913-017-2310-4

Ejemplares similares

Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs
por: Costa, Sarah, et al.
Publicado: (2019)

Drug pricing and reimbursement decision making systems in Mongolia
por: Dorj, Gereltuya, et al.
Publicado: (2017)

An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries
por: Ward, Leanne Marie, et al.
Publicado: (2022)

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies
por: Bloem, Lourens T., et al.
Publicado: (2021)

Decision maker perceptions of resource allocation processes in Canadian health care organizations: a national survey
por: Smith, Neale, et al.
Publicado: (2013)

Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
por: Detiček, Andreja, et al.
Publicado: (2018)

Reimbursement decision-making system in Poland systematically compared to other countries
por: Mela, Aneta, et al.
Publicado: (2023)

A proposed framework to improve the safety of medical devices in a Canadian hospital context
por: Polisena, Julie, et al.
Publicado: (2014)

Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand
por: Leopold, Christine, et al.
Publicado: (2020)

Building capacity for evidence-informed decision making in Canadian public health
por: Dobbins, Maureen, et al.
Publicado: (2015)

Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries
por: Malinowski, Krzysztof Piotr, et al.
Publicado: (2019)

Drug pricing and reimbursement information management: processes and decision making in the global economy
por: Tsourougiannis, Dimitrios
Publicado: (2017)

How Should the Value Attributes of Novel Antibiotics Be Considered in Reimbursement Decision Making?
por: Morton, Alec, et al.
Publicado: (2019)

In the works: Patient and public involvement and engagement in healthcare decision‐making
por: de Graaff, Bert, et al.
Publicado: (2021)

Rapid review programs to support health care and policy decision making: a descriptive analysis of processes and methods
por: Polisena, Julie, et al.
Publicado: (2015)

Engaging the public in healthcare decision-making: quantifying preferences for healthcare through citizens’ juries
por: Scuffham, Paul A, et al.
Publicado: (2014)

Role of centralized review processes for making reimbursement decisions on new health technologies in Europe
por: Stafinski, Tania, et al.
Publicado: (2011)

“Budget Impact Analyses”: A Practical Policy Making Tool for Drug Reimbursement Decisions
por: Jamshidi, Hamid Reza, et al.
Publicado: (2014)

The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?
por: Lux, Michael Patrick, et al.
Publicado: (2021)

Engaged scholarship and public policy decision-making: a scoping review
por: McIsaac, Jessie-Lee D., et al.
Publicado: (2020)

Public unawareness of physician reimbursement
por: Herrick, Nicole Lilly, et al.
Publicado: (2017)

Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement
por: Tse, Vicki C, et al.
Publicado: (2011)

Informed decision‐making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments
por: Weir, Christopher J., et al.
Publicado: (2022)

A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of Medicines
por: Bujar, Magdalena, et al.
Publicado: (2020)

Public engagement in decision‐making regarding the management of the COVID‐19 epidemic: Views and expectations of the ‘publics’
por: Kemper, Sophie, et al.
Publicado: (2022)

Engaging patients and public in decision‐making: approaches to achieving this in a complex environment
por: Chambers, Mary
Publicado: (2017)

Practices of decision making in priority setting and resource allocation: a scoping review and narrative synthesis of existing frameworks
por: Seixas, Brayan V., et al.
Publicado: (2021)

Pre-reimbursement: early assessment for coverage decisions
por: Grössmann, Nicole, et al.
Publicado: (2019)

An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries
por: Kamusheva, Maria, et al.
Publicado: (2018)

Characteristics of clinician input in Canadian funding decisions for cancer drugs: a cross-sectional study based on CADTH reimbursement recommendations
por: Jenei, Kristina, et al.
Publicado: (2023)

How Canadian seniors make decision about insolvency?
por: Amine, Samir, et al.
Publicado: (2023)

Quality of patient decision aids to support the public making COVID-19 decisions: An online environmental scan
por: Kiss, Alda, et al.
Publicado: (2023)

An Exploratory Analysis of Predictors of Concordance between Canadian Common Drug Review Reimbursement Recommendations and the Subsequent Decisions by Ontario, British Columbia and Alberta
por: Zoratti, Michael J., et al.
Publicado: (2020)

A Review and Comparative Analysis of Information Targeted to the General Public on the Websites of Breast Screening Programs in Canada
por: Kearney, Anne J., et al.
Publicado: (2017)

Patient and public engagement in decision-making regarding infectious disease outbreak management: an integrative review
por: Kemper, Sophie, et al.
Publicado: (2021)

Public perceptions uncovered: engaging in decision-making regarding non-pharmaceutical interventions: Sophie Kemper
por: Kemper, S, et al.
Publicado: (2022)

Using multicriteria decision analysis during drug development to predict reimbursement decisions
por: Williams, Paul, et al.
Publicado: (2014)

A checklist for managed access programmes for reimbursement co‐designed by Canadian patients and caregivers
por: Young, Andrea, et al.
Publicado: (2018)

Discontinuation of reimbursement of benzodiazepines in the Netherlands: does it make a difference?
por: Kollen, Boudewijn J, et al.
Publicado: (2012)

Health Economic Data in Reimbursement of New Medical Technologies: Importance of the Socio-Economic Burden as a Decision-Making Criterion
por: Iskrov, Georgi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gl0p4ski63t5nm4k5gqragdimf